Jafar Aslani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jafar Aslani has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Behzad Einollahi
Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 shared publications Babak Kardavani
Clinical Research Unit, Baqiyatallah University of Medical Sciences, Tehran, Iran
1 shared publicationEghlim Nemati
Nephrology and Urology Research Centre, Baqiyatallah University of Medical Sciences, Tehran, Iran
1 shared publication- Eghlim Nemati
Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
1 shared publication - Fariba Samadian1 shared publication
- Fatemeh Pour-Reza-Gholi1 shared publication
Latest Publications
- 1 January 2008
- Vol. 13 (4) , 55-8
Invasive fungal infections following renal transplantation: a review of 2410 recipients.
Organ transplant recipients, on long-term graft preserving immunosuppressive therapy, are at increased risk for life threatening opportunistic fungal infections. In order to evaluate the incidence of invasive fungal infections (IFIs) and to identify the most common fungal pathogens, we conducted a retrospective study on 2410 ESRD cases undergone living kidney transplantation in three transplant centers between 1998 and 2008. IFIs developed in 21 recipients (0.87%), 17 male and 4 female. Their immunosuppression was cyclosporine based. The mean age of patients was 48+/-10 (ranged from 32 to 67) years. Diagnosis was made by radiological findings, positive blood or bronchoalveolar lavage (BAL) cultures and tissue biopsies. Mucormycosis was the most common cause of IFIs in population studied (n=11), followed by disseminated candidiasis (n=4), aspergillosis (n=3), nocardiasis (n=2) and histoplasmosis (n=1). Pulmonary involvement was dominant (47.6%). The treatment was successful in only 10 patients and the rest died. In our large series of kidney transplant recipients, mucormycosis was found to be the most common cause of invasive fungal infection. Prompt diagnosis and treatment are necessary to avoid the life threatening complications and may greatly improve prognosis.
- 1 January 2008
- Vol. 13 (4) , 55-8
Invasive fungal infections following renal transplantation: a review of 2410 recipients.
Organ transplant recipients, on long-term graft preserving immunosuppressive therapy, are at increased risk for life threatening opportunistic fungal infections. In order to evaluate the incidence of invasive fungal infections (IFIs) and to identify the most common fungal pathogens, we conducted a retrospective study on 2410 ESRD cases undergone living kidney transplantation in three transplant centers between 1998 and 2008. IFIs developed in 21 recipients (0.87%), 17 male and 4 female. Their immunosuppression was cyclosporine based. The mean age of patients was 48+/-10 (ranged from 32 to 67) years. Diagnosis was made by radiological findings, positive blood or bronchoalveolar lavage (BAL) cultures and tissue biopsies. Mucormycosis was the most common cause of IFIs in population studied (n=11), followed by disseminated candidiasis (n=4), aspergillosis (n=3), nocardiasis (n=2) and histoplasmosis (n=1). Pulmonary involvement was dominant (47.6%). The treatment was successful in only 10 patients and the rest died. In our large series of kidney transplant recipients, mucormycosis was found to be the most common cause of invasive fungal infection. Prompt diagnosis and treatment are necessary to avoid the life threatening complications and may greatly improve prognosis.
- 1 January 2007
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 39 (8) , 703-706
Mucormycosis after kidney transplantations: Report of seven cases
This is a report of 7 cases of mucormycosis infections in patients who had undergone transplantation and been admitted in the kidney transplant centre of Baqiyatallah Hospital in Tehran, Iran, from 2002 to 2005. We retrospectively reviewed the hospital records for demographic data, symptoms, diagnostic techniques and outcomes. Five patients were male and 2 female. The mean age of patients was 49.5 y. The time interval between transplantation and disease onset varied greatly (range: 1 month to 4 y). Patients’ symptoms were fever (7 cases), respiratory distress (4 cases) and severe headache (3 cases). Suspected patients were evaluated by CT scan, BAL and biopsy and diagnosis confirmed by culture. The final diagnosis was pulmonary mucormycosis in 4 cases, rhino-cerebral mucormycosis in 2 cases and disseminated mucormycosis in 1 case. Despite early and intensive treatment with amphotericin B in all patients and extensive debridement in 3 cases, only 2 patients survived the disease. Mucormycosis is a potentially lethal complication after kidney transplantation. It could occur very early on or very late into the post-transplant period. Despite the results of other studies, the most frequent site of infection in our patients was the lungs.
- 1 January 2007
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 39 (8) , 703-706
Mucormycosis after kidney transplantations: Report of seven cases
This is a report of 7 cases of mucormycosis infections in patients who had undergone transplantation and been admitted in the kidney transplant centre of Baqiyatallah Hospital in Tehran, Iran, from 2002 to 2005. We retrospectively reviewed the hospital records for demographic data, symptoms, diagnostic techniques and outcomes. Five patients were male and 2 female. The mean age of patients was 49.5 y. The time interval between transplantation and disease onset varied greatly (range: 1 month to 4 y). Patients’ symptoms were fever (7 cases), respiratory distress (4 cases) and severe headache (3 cases). Suspected patients were evaluated by CT scan, BAL and biopsy and diagnosis confirmed by culture. The final diagnosis was pulmonary mucormycosis in 4 cases, rhino-cerebral mucormycosis in 2 cases and disseminated mucormycosis in 1 case. Despite early and intensive treatment with amphotericin B in all patients and extensive debridement in 3 cases, only 2 patients survived the disease. Mucormycosis is a potentially lethal complication after kidney transplantation. It could occur very early on or very late into the post-transplant period. Despite the results of other studies, the most frequent site of infection in our patients was the lungs.